Cargando…

Double-Blind Placebo-Controlled Pilot Investigation of the Safety of a Single Dose of Rapid-Acting Intranasal Insulin in Down Syndrome

BACKGROUND: Individuals with Down syndrome are likely to develop clinical and neuropathological brain changes resembling Alzheimer’s disease dementia by the ages of 35–40 years. Intranasal insulin is a potential treatment for neurodegenerative disease that has been shown to reduce amyloid plaque bur...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rosenbloom, Michael, Barclay, Terry, Johnsen, Justin, Erickson, Lauren, Svitak, Aleta, Pyle, Maria, Frey, William, Hanson, Leah R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2020
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7067723/ https://www.ncbi.nlm.nih.gov/pubmed/32077057 http://dx.doi.org/10.1007/s40268-020-00296-2

Ejemplares similares

Intranasal deferoxamine can improve memory in healthy C57 mice, suggesting a partially non‐disease‐specific pathway of functional neurologic improvement
por: Fine, Jared M., et al.
Publicado: (2020)

Intranasal Delivery of A Novel Amnion Cell Secretome Prevents Neuronal Damage and Preserves Function In A Mouse Multiple Sclerosis Model
por: Khan, Reas S., et al.
Publicado: (2017)

Intranasal Insulin Ameliorates Experimental Diabetic Neuropathy
por: Francis, George, et al.
Publicado: (2009)

Implementation and review of the care ecosystem in an integrated healthcare system
por: Rosenbloom, Michael H., et al.
Publicado: (2023)

Mechanisms of Intranasal Deferoxamine in Neurodegenerative and Neurovascular Disease
por: Kosyakovsky, Jacob, et al.
Publicado: (2021)

Safety of Intranasal Insulin in Type 2 Diabetes on Systemic Insulin: A Double-Blinded Placebo-Controlled Sub-Study of Memaid Trial
por: Aponte Becerra, L, et al.
Publicado: (2022)

Is there an effect of intranasal insulin on development and behaviour in Phelan-McDermid syndrome? A randomized, double-blind, placebo-controlled trial
por: Zwanenburg, Renée J, et al.
Publicado: (2016)

Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative disease
por: Hanson, Leah R, et al.
Publicado: (2008)

Intranasal Insulin Ameliorates Experimental Diabetic Neuropathy. Diabetes 2009;58:934–945. DOI: 10.2337/db08-1287
por: Francis, George, et al.
Publicado: (2014)

Safety and preliminary efficacy of intranasal insulin for cognitive impairment in Parkinson disease and multiple system atrophy: A double-blinded placebo-controlled pilot study
por: Novak, Peter, et al.
Publicado: (2019)

Intranasal Insulin for Alzheimer’s Disease
por: Hallschmid, Manfred
Publicado: (2021)

A Case of Minimally Progressive Prodromal Alzheimer’s Disease
por: Rosenbloom, Michael H., et al.
Publicado: (2023)

Effect of intranasal esketamine on cognitive functioning in healthy participants: a randomized, double-blind, placebo-controlled study
por: Morrison, Randall L., et al.
Publicado: (2018)

Intranasal insulin neuroprotection in ischemic stroke
por: Lioutas, Vasileios-Arsenios, et al.
Publicado: (2016)

Utility of intranasal Ketamine and Midazolam to perform gastric aspirates in children: a double-blind, placebo controlled, randomized study
por: Buonsenso, Danilo, et al.
Publicado: (2014)

Intranasal Ketamine for Depression in Adults: A Systematic Review and Meta-Analysis of Randomized, Double-Blind, Placebo-Controlled Trials
por: An, Dongjiao, et al.
Publicado: (2021)

The effect of intranasal oxytocin versus placebo treatment on the autonomic responses to human sounds in autism: a single-blind, randomized, placebo-controlled, crossover design study
por: Lin, I-Fan, et al.
Publicado: (2014)

The role of insulin sensitivity and intranasally applied insulin on olfactory perception
por: Edwin Thanarajah, Sharmili, et al.
Publicado: (2019)

Clinical effects of topical antifungal therapy in chronic rhinosinusitis: a randomized, double-blind, placebo-controlled trial of intranasal fluconazole
por: Hashemian, Farshad, et al.
Publicado: (2016)

Targeting Mediators of Smoking Persistence with Intranasal Insulin
por: Hamidovic, Ajna
Publicado: (2017)

Intranasal insulin in Alzheimer’s disease: Food for thought
por: Chapman, Colin D., et al.
Publicado: (2018)

Intranasal Insulin as a Treatment for Alzheimer’s Disease: A Review of Basic Research and Clinical Evidence
por: Freiherr, Jessica, et al.
Publicado: (2013)

Brain Glucose Hypometabolism and Iron Accumulation in Different Brain Regions in Alzheimer’s and Parkinson’s Diseases
por: Rao, Indira Y., et al.
Publicado: (2022)

Use of Intranasal Insulin as Neuroprotection From Hyperglycemia in Rat Model of Extremely Preterm Infants
por: Yauch, Lauren McClure, et al.
Publicado: (2021)

MemAID: Memory advancement with intranasal insulin vs. placebo in type 2 diabetes and control participants: a randomized clinical trial
por: Novak, Vera, et al.
Publicado: (2022)

The effects of intranasal esketamine (84 mg) and oral mirtazapine (30 mg) on on-road driving performance: a double-blind, placebo-controlled study
por: van de Loo, Aurora J. A. E., et al.
Publicado: (2017)

The effect of intranasal oxytocin on the perception of affective touch and multisensory integration in anorexia nervosa: protocol for a double-blind placebo-controlled crossover study
por: Crucianelli, Laura, et al.
Publicado: (2019)

Intranasal oxytocin versus placebo in the treatment of adults with autism spectrum disorders: a randomized controlled trial
por: Anagnostou, Evdokia, et al.
Publicado: (2012)

Efficacy of Self-Administered Intranasal Oxytocin on Alcohol Use and Craving After Detoxification in Patients With Alcohol Dependence. A Double-Blind Placebo-Controlled Trial
por: Melby, Katrine, et al.
Publicado: (2020)

Intranasal oxytocin administration impacts the acquisition and consolidation of trauma-associated memories: a double-blind randomized placebo-controlled experimental study in healthy women
por: Schultebraucks, Katharina, et al.
Publicado: (2021)

Efficacy and Safety of Intranasal Betahistine in the Treatment of Surgery-Induced Acute Vestibular Syndrome: A Double-Blind, Randomized, Placebo-Controlled Phase 2 Study
por: Van de Heyning, Paul, et al.
Publicado: (2023)

Pilot Randomized, Double-Blind, Placebo-Controlled Crossover Trial Evaluating the Feasibility of an Intranasal Oxytocin in Improving Social Cognition in Individuals Living with Alzheimer’s Disease
por: Michaelian, Johannes C., et al.
Publicado: (2023)

Enhancement of Vasoreactivity and Cognition by Intranasal Insulin in Type 2 Diabetes
por: Novak, Vera, et al.
Publicado: (2014)

Rapid transport of insulin to the brain following intranasal administration in rats
por: Fan, Lir-Wan, et al.
Publicado: (2019)

Distribution of insulin in trigeminal nerve and brain after intranasal administration
por: Lochhead, Jeffrey J., et al.
Publicado: (2019)

Odor Sensitivity After Intranasal Insulin Application Is Modulated by Gender
por: Rodriguez-Raecke, Rea, et al.
Publicado: (2018)

Intranasal Administration of KYCCSRK Peptide Rescues Brain Insulin Signaling Activation and Reduces Alzheimer’s Disease-like Neuropathology in a Mouse Model for Down Syndrome
por: Tramutola, Antonella, et al.
Publicado: (2023)

Diabetic Ketoacidosis Updates: Titratable Insulin Infusions and Long-Acting Insulin Early
por: Kinney, Justin, et al.
Publicado: (2021)

Efficacy of premedication with intranasal dexmedetomidine for removal of inhaled foreign bodies in children by flexible fiberoptic bronchoscopy: a randomized, double-blind, placebo-controlled clinical trial
por: Bi, Yanmei, et al.
Publicado: (2019)

A randomized, double-blind, placebo-controlled phase 1 trial of inhaled and intranasal niclosamide: A broad spectrum antiviral candidate for treatment of COVID-19
por: Backer, Vibeke, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_e829b1vk7hccofufso2n58m8e0